Related by context. Frequent words. (Click for all words.) 76 Patient Enrollment 76 Pivotal Phase III 75 Drug Candidate 74 Epratuzumab 74 Phase III Clinical Trial 74 Mipomersen 73 Clinical Trial Results 73 Boceprevir 73 Presents Positive 73 Phase III Trial 72 Pivotal Phase 72 Completes Enrollment 72 Chronic Hepatitis C 72 Preclinical Data 71 FDA Accepts 71 Aliskiren 71 Dasatinib 71 Ofatumumab 71 Cethromycin 70 MKC# 70 Recombinant Human 70 Generic Version 70 Voreloxin 69 Pivotal Trial 69 forodesine 69 Tesetaxel 69 INCB# [001] 69 PEG SN# 69 Monotherapy 69 KRN# 69 Eltrombopag 69 Metastatic Colorectal Cancer 68 Pirfenidone 68 Panzem R 68 Maraviroc 68 Cetrorelix 68 Avanafil 68 Monoclonal Antibody 68 Phase Ib clinical 68 Benign Prostatic Hyperplasia 68 Initiates Phase 68 phase IIb clinical 68 Carfilzomib 68 Metastatic Melanoma 68 Cholesterol Drug 68 Pulmonary Arterial Hypertension 68 Laquinimod 68 transcriptase inhibitor NNRTI 68 Abacavir 68 Diabetic Macular Edema 67 Well Tolerated 67 elotuzumab 67 Amrubicin 67 Vandetanib 67 Bevacizumab 67 Lamivudine 67 integrase inhibitor 67 Ixempra 67 Rexahn Pharmaceuticals 67 RNAi Therapeutics 67 HCV protease inhibitor 67 proteasome inhibitor 67 Alemtuzumab 67 Bavituximab 67 LY# [003] 67 Erlotinib 66 ACHN 66 ATL# [001] 66 pertuzumab 66 Phase IIb trials 66 Nexavar ® 66 SAR# [004] 66 NVA# 66 MEK inhibitor 66 mTOR inhibitor 66 registrational trial 66 Chronic Lymphocytic Leukemia 66 Hepatitis C Virus HCV 66 Lenalidomide 66 Hepatitis C Virus 66 metastatic castration resistant 66 Telaprevir 66 liposomal formulation 66 Entereg R 66 nucleoside analogue 66 Adalimumab 66 APTIVUS 66 Overactive Bladder 66 Hepatitis C HCV 66 transcriptase inhibitor 66 Cancer Vaccines 65 Allergic Rhinitis 65 BZL# 65 KNS # 65 Combination Therapy 65 multi kinase inhibitor 65 integrase inhibitors 65 aclidinium 65 Bortezomib 65 Naproxcinod 65 Clevudine